. Author manuscript; available in PMC: 2013 Jun 5.

Published in final edited form as: J Pediatr Ophthalmol Strabismus. 2011 Aug 30;49(3):146–156. doi: 10.3928/01913913-20110823-02

Table 3.

Cost-Effectiveness Results

	Costs and Effectiveness			Incremental Cost-Effectiveness Ratios		Incremental Net Benefit vs. Next Cost-Effective Scenario WTP = $25,000		Probability of Positive Cost-Effectiveness vs. Next Cost Effective Scenario WTP = $25,000
	Costs (CI)	QALYs (CI)	Cases Resolved Per 100 Screened	vs. No Screening	vs. Next Most Costly Scenario	Per QALY Gained (CI)	Per Case Resolved (CI)	Per QALY Gained	Per Case Resolved
No screening	$819 ($818 $820)	26.1261 (26.1259–26.1262)	–	–	–	–	–	–	–
A/S, K	$839 ($838 $840)	26.1274 (26.1272–26.1276)	0.4905 (0.4904–0.4906)	$15,000	$15,000	$2.07 ( $7.8 $12.0)	$103.0 ($101.1 $104.8)	0.660	1.000
A/S, PS & K	$858 ($857 $859)	26.1283 (26.1282–26.1285)	0.7584 (0.7583–0.7585)	$18,000	$22,000	$3.00 ($ 7.2 $13.2)	$55.4 ($44.8 $66.0)	0.718	1.00
Photo, PS + A/S at K	$872 ($871 $873)	26.1285 (26.1283–26.1287)	0.8247 (0.8246–0.8248)	$22,000	$78,000	$9.6 ( $20.2 $1.4)	$17.3 ($0.4 $34.2)	0.041	0.997

CI = credible interval for the simulated mean, A/S= acuity/stereopsis, Photo= photoscreening, PS = preschool; K = kindergarten